Log In
Print
BCIQ
Print
Print this Print this
 

KRN23

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionAnti fibroblast growth factor 23 (FGF23) human monoclonal antibody (mAb)
Molecular Target Fibroblast growth factor 23 (FGF23)
Mechanism of ActionAntibody
Latest Stage of DevelopmentPhase I/II
IndicationMusculoskeletal
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today